We have located links that may give you full text access.
Case Reports
Journal Article
Symptomatic-low grade methemoglobinemia because of dapsone: a multiple hit hypothesis.
American Journal of Therapeutics 2013 November
Methemoglobinemia occurs when hemoglobin is oxidized to form methemoglobin (MetHb) rendering it incapable of oxygen transport and leading to tissue hypoxia. Typically, protective mechanisms keep MetHb levels below 1%, but a variety of compounds are capable of inducing methemoglobinemia including dapsone. Normally, symptoms correlate with MetHb level and treatment with methylene blue is reserved for patients with significantly elevated MetHb levels. We present a case of symptomatic low-grade methemoglobinemia because of dapsone therapy. This case illustrates a multiple hit hypothesis where comorbid conditions prompt symptoms at a low MetHb level. Understanding the impact of comorbid conditions in exacerbating low-grade methemoglobinemia is important in diagnosing and managing this condition. Treatment with methylene blue should be guided by the whole clinical picture rather than by the MetHb level alone.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app